Work

Author response for "Advancing therapy with iGlarLixi versus Premix 70/30 in basal insulin‐treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomised controlled trial"

Year: 2021

Type: peer-review

DOI: 10.1111/dom.14354/v2/response1

Authors: Rory J. McCrimmon, Saud Al Sifri, Rifat Emral, Viswanathan Mohan, Leobardo Sauque‐Reyna, Carlos Trescolí, Nebojsa Lalic, Agustina Alvarez, Nacima Demil, Mathieu Coudert, Alka Shaunik, Mireille Bonnemaire, Julio Rosenstock, SoliMix Trial investigators

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W3130309558

Cites:

Cited by:

Related to: 10